Skip to search formSkip to main contentSkip to account menu

Varivax

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Chickenpox Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A double-blind, randomized, controlled, multi-center safety and immunogenicity study of a refrigerator-stable formulation of VARIVAX®.
2018
2018
Measles, Mumps and Rubell (MMR)
All children without contraindications should receive two doses of measles-mumps-rubella combination vaccine (abbreviation: MMR… 
2010
2010
The effectiveness of Varivax and Varilrix vaccines.
2009
2009
Safety of a refrigerator-stable varicella vaccine (VARIVAX®) in healthy 12- to 15-month-old children – a randomized, double-blind, cross-over study
The safety of a single injection of the refrigerator-stable formulation of varicella vaccine VARIVAX® was assessed in a blind… 
2008
2008
Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program.
BACKGROUND Varicella vaccine currently is recommended for children between 12 and 18 months of age. However, rates of… 
2006
2006
Genotyping of different varicella vaccine strains.
Highly Cited
2006
Highly Cited
2006
Safety and Immunogenicity of a Combination: Measles, Mumps, Rubella and Varicella Vaccine (ProQuad®)
Background: A combination measles, mumps, rubella, and varicella vaccine (ProQuad®, Merck & Co., Inc, West Point, PA) was… 
Review
2002
Review
2002
Varivax (Merck & Co).
Varivax is a live-attenuated varicella vaccine developed and launched in the US by Merck & Co for the treatment of chickenpox… 
1998
1998
Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE…
OBJECTIVES AND STUDY DESIGN The primary objectives of this study were to compare immunologic responses, antibody persistence… 
1995
1995
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group.
A multicenter clinical trial was conducted among 757 healthy adolescents and adults, 13-54 years, to compare two regimens of Oka… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)